Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires; Scott Leffler Appointed as Successor; Restatement of Previously Issued Financial Guidance

Myriad Genetics Chief Financial Officer Bryan Riggsbee Retires;  Scott Leffler Appointed as Successor;  Restatement of Previously Issued Financial Guidance

SALT LAKE CITY, Dec. 21, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN ), a leader in genetic testing and precision medicine, today announced the appointment of Scott Leffler …

Read more